• -
  • English
  • Japanese
  • Korean
市場調查報告書
商品編碼
1021849

基因編輯的全球市場:技術，用途，輸送手法，終端用戶，各地區，競爭，預測和機會(2026年)

Global Genome Editing Market, By Technique, By Application, By Delivery Method, By End User, By Region, Competition Forecast & Opportunities, 2026
出版日期: | 出版商: TechSci Research | 英文 110 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

  • 全貌
  • 簡介
  • 目錄
簡介

全球基因編輯的市場規模，在預測期間內預計以12.73％的年複合成長率成長，預計2026年達到87億1,124萬美元。

以各種慢性疾病的治療為目的的研究開發活動的活躍，及個人化醫療的偏好高漲，推動至2026年的市場成長。還有隨著慢性疾病和感染疾病增加，預計今後數年基因編輯的適用範圍擴大。

本報告提供全球基因編輯市場的相關調查，市場規模和預測，佔有率，COVID-19的影響，成長要素和課題，各技術、用途、輸送手法、終端用戶、各地區的市場分析，競爭情形，主要企業的簡介等資訊。

目錄

第1章 產品概要

第2章 調查手法

第3章 客戶的迴響

  • 全球基因編輯市場的推動因素
  • 技術的兼容性
  • 未滿足需求與課題

第4章 COVID-19對全球基因編輯市場的影響

第5章 摘要整理

第6章 全球基因編輯市場預測

  • 市場規模與預測
    • 各銷售額
  • 市場佔有率與預測
    • 各技術(CRISPR，TALEN，鋅指核酸酶，其他)
    • 各用途(細胞株工程，動物基因工程學，植物基因工程學，其他)
    • 各輸送手法(ex-vivo，in-vivo)
    • 各終端用戶(醫藥、生物科技企業，臨床調查機關，調查機關)
    • 各企業:2020年
    • 各地區
  • 產品市場地圖

第7章 北美的基因編輯市場預測

  • 市場規模與預測
    • 各銷售額
  • 市場佔有率與預測
    • 各技術
    • 各用途
    • 各輸送手法
    • 各終端用戶
    • 各國
  • 北美:各國分析
    • 美國的基因編輯市場預測
    • 加拿大的基因編輯市場預測
    • 墨西哥的基因編輯市場預測

第8章 歐洲的基因編輯市場預測

  • 市場規模與預測
    • 各銷售額
  • 市場佔有率與預測
    • 各技術
    • 各用途
    • 各輸送手法
    • 各終端用戶
    • 各國
  • 歐洲:各國分析
    • 德國的基因編輯市場預測
    • 英國的基因編輯市場預測
    • 法國基因編輯市場預測
    • 義大利基因編輯市場預測
    • 西班牙基因編輯市場預測

第9章 亞太地區的基因編輯市場預測

  • 市場規模與預測
    • 各銷售額
  • 市場佔有率與預測
    • 各技術
    • 各用途
    • 各輸送手法
    • 各終端用戶
    • 各國
  • 亞太地區:各國分析
    • 中國的基因編輯市場預測
    • 日本的基因編輯市場預測
    • 印度的基因編輯市場預測
    • 韓國的基因編輯市場預測
    • 澳洲的基因編輯市場預測

第10章 南美的基因編輯市場預測

  • 市場規模與預測
    • 各銷售額
  • 市場佔有率與預測
    • 各技術
    • 各用途
    • 各輸送手法
    • 各終端用戶
    • 各國
  • 南美:各國分析
    • 巴西的基因編輯市場預測
    • 阿根廷的基因編輯市場預測
    • 哥倫比亞的基因編輯市場預測

第11章 中東及非洲的基因編輯市場預測

  • 市場規模與預測
    • 各銷售額
  • 市場佔有率與預測
    • 各技術
    • 各用途
    • 各輸送手法
    • 各終端用戶
    • 各國
  • 中東、非洲:各國分析
    • 南非的基因編輯市場預測
    • 沙烏地阿拉伯的基因編輯市場預測
    • 阿拉伯聯合大公國的基因編輯市場預測

第12章 市場動態

  • 成長要素
  • 課題

第13章 市場趨勢

第14章 競爭情形

  • 競爭預測
  • 企業簡介(主要企業)
    • Thermo Fisher Scientific Inc.
    • Homology Medicines, Inc.
    • CRISPR Therapeutics AG
    • Pfizer Inc.
    • Editas Medicine Inc.
    • Intellia Therapeutics Inc.
    • Cellectis SA
    • Sangamo Therapeutics Inc.
    • Origene Technologies Inc.
    • Merck & Co Inc.
    • New England Biolabs Inc.
    • Lonza Group AG
    • Danaher Corporation(Integrated DNA Technologies Inc.)
    • PerkinElmer Inc.(Horizon Discovery Group Plc)
    • Genscript Corp.
    • Oxford Genetics Ltd.
    • Bayer AG
    • Arcturus Therapeutics Inc
    • Inscripta Inc.
    • Beam therapeutics Inc.

第15章 策略性建議

第16章 關於本公司&免責聲明

目錄
Product Code: 4542

Global genome editing market is expected to reach USD8711.24 million by 2026, growing at double-digit CAGR of 12.73% over the forecast period. Growing research & development activities for the treatment of various chronic diseases and increasing preference for personalized medicine are fueling the market growth of genome editing until 2026.

Genome editing is a way of making specific changes to the DNA of a cell or organism. It could be used to edit the genome of any organism. It uses a type of enzyme called an 'engineered nuclease' which cuts the genome in a specific place. After cutting the DNA in a specific place, the cell naturally repairs itself. It finds application in large number of areas, such as mutation, therapeutics, and agriculture biotechnology. Rise in the number of chronic and infectious diseases is likely to expand the scope of genome editing in the coming years.

The global genome editing market is segmented based on technique, application, delivery method, end-user, region and company. Based on technique, the market is segmented into CRISPR, TALENs, Zinc Finger Nucleases and others. CRISPR dominates the market in this segment and is expected to be the fastest growing segment because as it is cheaper and is the most efficient technique among the rest. Based on application, the market is segmented into cell line engineering, animal genetic engineering, plant genetic engineering and others. Among them, the cell line engineering is expected to witness the highest growth rate in the coming years due to increase in the number of people suffering with genetic disorders and rising government funding for stem cell research.

Based on end-user, the global genome editing market is segmented into pharmaceutical & biotechnology companies, clinical research organization and research institutes. Pharmaceutical & biotechnology companies contribute to the largest share of revenue generation for global genome editing market. Growing establishment of biotech and pharma companies in emerging economies and growing usage of gene editing technique in research activities undertaken by them to manufacture and develop drugs for rare diseases are the enablers for the growth of the market.

The major players operating in the global genome editing market are Thermo Fisher Scientific Inc., Homology Medicines, Inc., CRISPR Therapeutics AG, Pfizer Inc., Editas Medicine Inc., Intellia Therapeutics Inc., Cellectis SA, Sangamo Therapeutics Inc., Origene Technologies Inc., Merck & Co Inc., New England Biolabs Inc., Lonza Group AG, Danaher Corporation (Integrated DNA Technologies Inc.), PerkinElmer Inc. (Horizon Discovery Group Plc), Genscript Corp., Oxford Genetics Ltd., Bayer AG, Arcturus Therapeutics Inc, Inscripta Inc., Beam therapeutics Inc. and others. Growing number of research and development is going to drive the genome editing market in the coming years.

Years considered for this report:

Historical Years: 2016-2019

Base Year: 2020

Estimated Year: 2021

Forecast Period: 2022- 2026

Objective of the Study:

  • To analyze the historical growth in the market size of global genome editing market from 2016 to 2020.
  • To estimate and forecast the market size of global genome editing market from 2021 to 2026 and growth rate until 2026.
  • To classify and forecast global genome editing market based on technique, application, delivery method, end user, company and region.
  • To identify drivers and challenges for global genome editing market.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in global genome editing market.
  • To conduct pricing analysis for global genome editing market.
  • To identify and analyze the profile of leading players operating in global genome editing market.

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of companies across the globe. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the companies which could not be identified due to the limitations of secondary research. TechSci Research analyzed the presence of all major players across the globe.

TechSci Research calculated the market size of global genome editing market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.

Key Target Audience:

  • Genome editing companies
  • Market research and consulting firms
  • Government bodies such as regulating authorities and policy makers
  • Organizations, forums and alliances related to genome editing

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as companies, partners, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope:

In this report, global genome editing market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • Global Genome Editing Market, By Technique:

CRISPR

TALENs

Zinc Finger Nucleases

Others

  • Global Genome Editing Market, By Application:

Cell Line Engineering

Animal Genetic Engineering

Plant Genetic Engineering

Others

  • Global Genome Editing Market, By Delivery Method:

Ex-vivo

In-vivo

  • Global Genome Editing Market, By End User:

Pharmaceutical & Biotechnology Companies

Clinical Research Organization

Research Institutes

  • Global Genome Editing Market, By Region:

North America

Europe

Asia Pacific

South America

Middle East and Africa

Competitive Landscape:

Company Profiles: Detailed analysis of the major companies present in global genome editing market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

2. Research Methodology

3. Voice of Customer

  • 3.1. Factors Driving the Global Genome Editing Market
  • 3.2. Technology Compatibility
  • 3.3. Unmet Needs and Challenges

4. Impact of COVID-19 on Global Genome Editing Market

5. Executive Summary

6. Global Genome Editing Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Technique (CRISPR, TALENs, Zinc Finger Nucleases, Others)
    • 6.2.2. By Application (Cell Line Engineering, Animal Genetic Engineering, Plant Genetic Engineering, Others)
    • 6.2.3. By Delivery Method (Ex-vivo, In-vivo)
    • 6.2.4. By End User (Pharmaceutical & Biotechnology Companies, Clinical Research Organization, Research Institutes)
    • 6.2.5. By Company (2020)
    • 6.2.6. By Region
  • 6.3. Product Market Map

7. North America Genome Editing Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Technique
    • 7.2.2. By Application
    • 7.2.3. By Delivery Method
    • 7.2.4. By End User
    • 7.2.5. By Country
  • 7.3. North America: Country Analysis
    • 7.3.1. United States Genome Editing Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Technique
        • 7.3.1.2.2. By Application
        • 7.3.1.2.3. By Delivery Method
        • 7.3.1.2.4. By End User
    • 7.3.2. Canada Genome Editing Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Technique
        • 7.3.2.2.2. By Application
        • 7.3.2.2.3. By Delivery Method
        • 7.3.2.2.4. By End User
    • 7.3.3. Mexico Genome Editing Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Technique
        • 7.3.3.2.2. By Application
        • 7.3.3.2.3. By Delivery Method
        • 7.3.3.2.4. By End User

8. Europe Genome Editing Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Technique
    • 8.2.2. By Application
    • 8.2.3. By Delivery Method
    • 8.2.4. By End User
    • 8.2.5. By Country
  • 8.3. Europe: Country Analysis
    • 8.3.1. Germany Genome Editing Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Technique
        • 8.3.1.2.2. By Application
        • 8.3.1.2.3. By Delivery Method
        • 8.3.1.2.4. By End User
    • 8.3.2. United Kingdom Genome Editing Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Technique
        • 8.3.2.2.2. By Application
        • 8.3.2.2.3. By Delivery Method
        • 8.3.2.2.4. By End User
    • 8.3.3. France Genome Editing Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Technique
        • 8.3.3.2.2. By Application
        • 8.3.3.2.3. By Delivery Method
        • 8.3.3.2.4. By End User
    • 8.3.4. Italy Genome Editing Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Technique
        • 8.3.4.2.2. By Application
        • 8.3.4.2.3. By Delivery Method
        • 8.3.4.2.4. By End User
    • 8.3.5. Spain Genome Editing Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Technique
        • 8.3.5.2.2. By Application
        • 8.3.5.2.3. By Delivery Method
        • 8.3.5.2.4. By End User

9. Asia-Pacific Genome Editing Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Technique
    • 9.2.2. By Application
    • 9.2.3. By Delivery Method
    • 9.2.4. By End User
    • 9.2.5. By Country
  • 9.3. Asia-Pacific: Country Analysis
    • 9.3.1. China Genome Editing Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Technique
        • 9.3.1.2.2. By Application
        • 9.3.1.2.3. By Delivery Method
        • 9.3.1.2.4. By End User
    • 9.3.2. Japan Genome Editing Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Technique
        • 9.3.2.2.2. By Application
        • 9.3.2.2.3. By Delivery Method
        • 9.3.2.2.4. By End User
    • 9.3.3. India Genome Editing Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Technique
        • 9.3.3.2.2. By Application
        • 9.3.3.2.3. By Delivery Method
        • 9.3.3.2.4. By End User
    • 9.3.4. South Korea Genome Editing Market Outlook
      • 9.3.4.1. Market Size & Forecast
        • 9.3.4.1.1. By Value
      • 9.3.4.2. Market Share & Forecast
        • 9.3.4.2.1. By Technique
        • 9.3.4.2.2. By Application
        • 9.3.4.2.3. By Delivery Method
        • 9.3.4.2.4. By End User
    • 9.3.5. Australia Genome Editing Market Outlook
      • 9.3.5.1. Market Size & Forecast
        • 9.3.5.1.1. By Value
      • 9.3.5.2. Market Share & Forecast
        • 9.3.5.2.1. By Technique
        • 9.3.5.2.2. By Application
        • 9.3.5.2.3. By Delivery Method
        • 9.3.5.2.4. By End User

10. South America Genome Editing Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Technique
    • 10.2.2. By Application
    • 10.2.3. By Delivery Method
    • 10.2.4. By End User
    • 10.2.5. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Genome Editing Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Technique
        • 10.3.1.2.2. By Application
        • 10.3.1.2.3. By Delivery Method
        • 10.3.1.2.4. By End User
    • 10.3.2. Argentina Genome Editing Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Technique
        • 10.3.2.2.2. By Application
        • 10.3.2.2.3. By Delivery Method
        • 10.3.2.2.4. By End User
    • 10.3.3. Colombia Genome Editing Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Technique
        • 10.3.3.2.2. By Application
        • 10.3.3.2.3. By Delivery Method
        • 10.3.3.2.4. By End User

11. Middle East and Africa Genome Editing Market Outlook

  • 11.1. Market Size & Forecast
    • 11.1.1. By Value
  • 11.2. Market Share & Forecast
    • 11.2.1. By Technique
    • 11.2.2. By Application
    • 11.2.3. By Delivery Method
    • 11.2.4. By End User
    • 11.2.5. By Country
  • 11.3. MEA: Country Analysis
    • 11.3.1. South Africa Genome Editing Market Outlook
      • 11.3.1.1. Market Size & Forecast
        • 11.3.1.1.1. By Value
      • 11.3.1.2. Market Share & Forecast
        • 11.3.1.2.1. By Technique
        • 11.3.1.2.2. By Application
        • 11.3.1.2.3. By Delivery Method
        • 11.3.1.2.4. By End User
    • 11.3.2. Saudi Arabia Genome Editing Market Outlook
      • 11.3.2.1. Market Size & Forecast
        • 11.3.2.1.1. By Value
      • 11.3.2.2. Market Share & Forecast
        • 11.3.2.2.1. By Technique
        • 11.3.2.2.2. By Application
        • 11.3.2.2.3. By Delivery Method
        • 11.3.2.2.4. By End User
    • 11.3.3. UAE Genome Editing Market Outlook
      • 11.3.3.1. Market Size & Forecast
        • 11.3.3.1.1. By Value
      • 11.3.3.2. Market Share & Forecast
        • 11.3.3.2.1. By Technique
        • 11.3.3.2.2. By Application
        • 11.3.3.2.3. By Delivery Method
        • 11.3.3.2.4. By End User

12. Market Dynamics

  • 12.1. Drivers
  • 12.2. Challenges

13. Market Trends & Developments

14. Competitive Landscape

  • 14.1. Competition Outlook
  • 14.2. Players Profiled (Leading Companies)
    • 14.2.1. Thermo Fisher Scientific Inc.
    • 14.2.2. Homology Medicines, Inc.
    • 14.2.3. CRISPR Therapeutics AG
    • 14.2.4. Pfizer Inc.
    • 14.2.5. Editas Medicine Inc.
    • 14.2.6. Intellia Therapeutics Inc.
    • 14.2.7. Cellectis SA
    • 14.2.8. Sangamo Therapeutics Inc.
    • 14.2.9. Origene Technologies Inc.
    • 14.2.10. Merck & Co Inc.
    • 14.2.11. New England Biolabs Inc.
    • 14.2.12. Lonza Group AG
    • 14.2.13. Danaher Corporation (Integrated DNA Technologies Inc.)
    • 14.2.14. PerkinElmer Inc. (Horizon Discovery Group Plc)
    • 14.2.15. Genscript Corp.
    • 14.2.16. Oxford Genetics Ltd.
    • 14.2.17. Bayer AG
    • 14.2.18. Arcturus Therapeutics Inc
    • 14.2.19. Inscripta Inc.
    • 14.2.20. Beam therapeutics Inc.

15. Strategic Recommendations

16. About Us & Disclaimer

List of Figures

  • Figure 1: Global Genome Editing Market Size, By Value (USD Million), 2016-2026F
  • Figure 2: Global Genome Editing Market Share, By Technique, By Value, 2016-2026F
  • Figure 3: Global Genome Editing Market Share, By Application, By Value, 2016-2026F
  • Figure 4: Global Genome Editing Market Share, By Delivery Method, By Value, 2016-2026F
  • Figure 5: Global Genome Editing Market Share, By End User, By Value, 2016-2026F
  • Figure 6: Global Genome Editing Market Share, By Company, By Value, 2020
  • Figure 7: Global Genome Editing Market Share, By Region, By Value, 2016-2026F
  • Figure 8: Global Genome Editing Product Market Map, By Value, 2016-2026F
  • Figure 9: North America Genome Editing Market Size, By Value (USD Million), 2016-2026F
  • Figure 10: North America Genome Editing Market Share, By Technique, By Value, 2016-2026F
  • Figure 11: North America Genome Editing Market Share, By Application, By Value, 2016-2026F
  • Figure 12: North America Genome Editing Market Share, By Delivery Method, By Value, 2016-2026F
  • Figure 13: North America Genome Editing Market Share, By End User, By Value, 2016-2026F
  • Figure 14: North America Genome Editing Market Share, By Country, By Value, 2016-2026F
  • Figure 15: United States Genome Editing Market Size, By Value (USD Million), 2016-2026F
  • Figure 16: United States Genome Editing Market Share, By Technique, By Value, 2016-2026F
  • Figure 17: United States Genome Editing Market Share, By Application, By Value, 2016-2026F
  • Figure 18: United States Genome Editing Market Share, By Delivery Method, By Value, 2016-2026F
  • Figure 19: United States Genome Editing Market Share, By End User, By Value, 2016-2026F
  • Figure 20: Canada Genome Editing Market Size, By Value (USD Million), 2016-2026F
  • Figure 21: Canada Genome Editing Market Share, By Technique, By Value, 2016-2026F
  • Figure 22: Canada Genome Editing Market Share, By Application, By Value, 2016-2026F
  • Figure 23: Canada Genome Editing Market Share, By Delivery Method, By Value, 2016-2026F
  • Figure 24: Canada Genome Editing Market Share, By End User, By Value, 2016-2026F
  • Figure 25: Mexico Genome Editing Market Size, By Value (USD Million), 2016-2026F
  • Figure 26: Mexico Genome Editing Market Share, By Technique, By Value, 2016-2026F
  • Figure 27: Mexico Genome Editing Market Share, By Application, By Value, 2016-2026F
  • Figure 28: Mexico Genome Editing Market Share, By Delivery Method, By Value, 2016-2026F
  • Figure 29: Mexico Genome Editing Market Share, By End User, By Value, 2016-2026F
  • Figure 30: Europe Genome Editing Market Size, By Value (USD Million), 2016-2026F
  • Figure 31: Europe Genome Editing Market Share, By Technique, By Value, 2016-2026F
  • Figure 32: Europe Genome Editing Market Share, By Application, By Value, 2016-2026F
  • Figure 33: Europe Genome Editing Market Share, By Delivery Method, By Value, 2016-2026F
  • Figure 34: Europe Genome Editing Market Share, By End User, By Value, 2016-2026F
  • Figure 35: Europe Genome Editing Market Share, By Country, By Value, 2016-2026F
  • Figure 36: Germany Genome Editing Market Size, By Value (USD Million), 2016-2026F
  • Figure 37: Germany Genome Editing Market Share, By Technique, By Value, 2016-2026F
  • Figure 38: Germany Genome Editing Market Share, By Application, By Value, 2016-2026F
  • Figure 39: Germany Genome Editing Market Share, By Delivery Method, By Value, 2016-2026F
  • Figure 40: Germany Genome Editing Market Share, By End User, By Value, 2016-2026F
  • Figure 41: United Kingdom Genome Editing Market Size, By Value (USD Million), 2016-2026F
  • Figure 42: United Kingdom Genome Editing Market Share, By Technique, By Value, 2016-2026F
  • Figure 43: United Kingdom Genome Editing Market Share, By Application, By Value, 2016-2026F
  • Figure 44: United Kingdom Genome Editing Market Share, By Delivery Method, By Value, 2016-2026F
  • Figure 45: United Kingdom Genome Editing Market Share, By End User, By Value, 2016-2026F
  • Figure 46: France Genome Editing Market Size, By Value (USD Million), 2016-2026F
  • Figure 47: France Genome Editing Market Share, By Technique, By Value, 2016-2026F
  • Figure 48: France Genome Editing Market Share, By Application, By Value, 2016-2026F
  • Figure 49: France Genome Editing Market Share, By Delivery Method, By Value, 2016-2026F
  • Figure 50: France Genome Editing Market Share, By End User, By Value, 2016-2026F
  • Figure 51: Italy Genome Editing Market Size, By Value (USD Million), 2016-2026F
  • Figure 52: Italy Genome Editing Market Share, By Technique, By Value, 2016-2026F
  • Figure 53: Italy Genome Editing Market Share, By Application, By Value, 2016-2026F
  • Figure 54: Italy Genome Editing Market Share, By Delivery Method, By Value, 2016-2026F
  • Figure 55: Italy Genome Editing Market Share, By End User, By Value, 2016-2026F
  • Figure 56: Spain Genome Editing Market Size, By Value (USD Million), 2016-2026F
  • Figure 57: Spain Genome Editing Market Share, By Technique, By Value, 2016-2026F
  • Figure 58: Spain Genome Editing Market Share, By Application, By Value, 2016-2026F
  • Figure 59: Spain Genome Editing Market Share, By Delivery Method, By Value, 2016-2026F
  • Figure 60: Spain Genome Editing Market Share, By End User, By Value, 2016-2026F
  • Figure 61: Asia-Pacific Genome Editing Market Size, By Value (USD Million), 2016-2026F
  • Figure 62: Asia-Pacific Genome Editing Market Share, By Technique, By Value, 2016-2026F
  • Figure 63: Asia-Pacific Genome Editing Market Share, By Application, By Value, 2016-2026F
  • Figure 64: Asia-Pacific Genome Editing Market Share, By Delivery Method, By Value, 2016-2026F
  • Figure 65: Asia-Pacific Genome Editing Market Share, By End User, By Value, 2016-2026F
  • Figure 66: Asia-Pacific Genome Editing Market Share, By Country, By Value, 2016-2026F
  • Figure 67: China Genome Editing Market Size, By Value (USD Million), 2016-2026F
  • Figure 68: China Genome Editing Market Share, By Technique, By Value, 2016-2026F
  • Figure 69: China Genome Editing Market Share, By Application, By Value, 2016-2026F
  • Figure 70: China Genome Editing Market Share, By Delivery Method, By Value, 2016-2026F
  • Figure 71: China Genome Editing Market Share, By End User, By Value, 2016-2026F
  • Figure 72: Japan Genome Editing Market Size, By Value (USD Million), 2016-2026F
  • Figure 73: Japan Genome Editing Market Share, By Technique, By Value, 2016-2026F
  • Figure 74: Japan Genome Editing Market Share, By Application, By Value, 2016-2026F
  • Figure 75: Japan Genome Editing Market Share, By Delivery Method, By Value, 2016-2026F
  • Figure 76: Japan Genome Editing Market Share, By End User, By Value, 2016-2026F
  • Figure 77: India Genome Editing Market Size, By Value (USD Million), 2016-2026F
  • Figure 78: India Genome Editing Market Share, By Technique, By Value, 2016-2026F
  • Figure 79: India Genome Editing Market Share, By Application, By Value, 2016-2026F
  • Figure 80: India Genome Editing Market Share, By Delivery Method, By Value, 2016-2026F
  • Figure 81: India Genome Editing Market Share, By End User, By Value, 2016-2026F
  • Figure 82: South Korea Genome Editing Market Size, By Value (USD Million), 2016-2026F
  • Figure 83: South Korea Genome Editing Market Share, By Technique, By Value, 2016-2026F
  • Figure 84: South Korea Genome Editing Market Share, By Application, By Value, 2016-2026F
  • Figure 85: South Korea Genome Editing Market Share, By Delivery Method, By Value, 2016-2026F
  • Figure 86: South Korea Genome Editing Market Share, By End User, By Value, 2016-2026F
  • Figure 87: Australia Genome Editing Market Size, By Value (USD Million), 2016-2026F
  • Figure 88: Australia Genome Editing Market Share, By Technique, By Value, 2016-2026F
  • Figure 89: Australia Genome Editing Market Share, By Application, By Value, 2016-2026F
  • Figure 90: Australia Genome Editing Market Share, By Delivery Method, By Value, 2016-2026F
  • Figure 91: Australia Genome Editing Market Share, By End User, By Value, 2016-2026F
  • Figure 92: South America Genome Editing Market Size, By Value (USD Million), 2016-2026F
  • Figure 93: South America Genome Editing Market Share, By Technique, By Value, 2016-2026F
  • Figure 94: South America Genome Editing Market Share, By Application, By Value, 2016-2026F
  • Figure 95: South America Genome Editing Market Share, By Delivery Method, By Value, 2016-2026F
  • Figure 96: South America Genome Editing Market Share, By End User, By Value, 2016-2026F
  • Figure 97: South America Genome Editing Market Share, By Country, By Value, 2016-2026F
  • Figure 98: Brazil Genome Editing Market Size, By Value (USD Million), 2016-2026F
  • Figure 99: Brazil Genome Editing Market Share, By Technique, By Value, 2016-2026F
  • Figure 100: Brazil Genome Editing Market Share, By Application, By Value, 2016-2026F
  • Figure 101: Brazil Genome Editing Market Share, By Delivery Method, By Value, 2016-2026F
  • Figure 102: Brazil Genome Editing Market Share, By End User, By Value, 2016-2026F
  • Figure 103: Argentina Genome Editing Market Size, By Value (USD Million), 2016-2026F
  • Figure 104: Argentina Genome Editing Market Share, By Technique, By Value, 2016-2026F
  • Figure 105: Argentina Genome Editing Market Share, By Application, By Value, 2016-2026F
  • Figure 106: Argentina Genome Editing Market Share, By Delivery Method, By Value, 2016-2026F
  • Figure 107: Argentina Genome Editing Market Share, By End User, By Value, 2016-2026F
  • Figure 108: Colombia Genome Editing Market Size, By Value (USD Million), 2016-2026F
  • Figure 109: Colombia Genome Editing Market Share, By Technique, By Value, 2016-2026F
  • Figure 110: Colombia Genome Editing Market Share, By Application, By Value, 2016-2026F
  • Figure 111: Colombia Genome Editing Market Share, By Delivery Method, By Value, 2016-2026F
  • Figure 112: Colombia Genome Editing Market Share, By End User, By Value, 2016-2026F
  • Figure 113: Middle East and Africa Genome Editing Market Size, By Value (USD Million), 2016-2026F
  • Figure 114: Middle East and Africa Genome Editing Market Share, By Technique, By Value, 2016-2026F
  • Figure 115: Middle East and Africa Genome Editing Market Share, By Application, By Value, 2016-2026F
  • Figure 116: Middle East and Africa Genome Editing Market Share, By Delivery Method, By Value, 2016-2026F
  • Figure 117: Middle East and Africa Genome Editing Market Share, By End User, By Value, 2016-2026F
  • Figure 118: Middle East and Africa Genome Editing Market Share, By Country, By Value, 2016-2026F
  • Figure 119: South Africa Genome Editing Market Size, By Value (USD Million), 2016-2026F
  • Figure 120: South Africa Genome Editing Market Share, By Technique, By Value, 2016-2026F
  • Figure 121: South Africa Genome Editing Market Share, By Application, By Value, 2016-2026F
  • Figure 122: South Africa Genome Editing Market Share, By Delivery Method, By Value, 2016-2026F
  • Figure 123: South Africa Genome Editing Market Share, By End User, By Value, 2016-2026F
  • Figure 124: Saudi Arabia Genome Editing Market Size, By Value (USD Million), 2016-2026F
  • Figure 125: Saudi Arabia Genome Editing Market Share, By Technique, By Value, 2016-2026F
  • Figure 126: Saudi Arabia Genome Editing Market Share, By Application, By Value, 2016-2026F
  • Figure 127: Saudi Arabia Genome Editing Market Share, By Delivery Method, By Value, 2016-2026F
  • Figure 128: Saudi Arabia Genome Editing Market Share, By End User, By Value, 2016-2026F
  • Figure 129: UAE Genome Editing Market Size, By Value (USD Million), 2016-2026F
  • Figure 130: UAE Genome Editing Market Share, By Technique, By Value, 2016-2026F
  • Figure 131: UAE Genome Editing Market Share, By Application, By Value, 2016-2026F
  • Figure 132: UAE Genome Editing Market Share, By Delivery Method, By Value, 2016-2026F
  • Figure 133: UAE Genome Editing Market Share, By End User, By Value, 2016-2026F